Floatz logo

Cyclophosphamide

T-Cell Prolymphocytic Leukemia

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologySmall moleculePhase 2Dormant
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the T-Cell Prolymphocytic Leukemia cohort.

Asset / SponsorPhaseRating
Cytosin-Arabinosid
M.D. Anderson Cancer Center
Phase 2BB
Fludarabine
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 3BB
ETOPOSIDE
Fred Hutchinson Cancer Center
Phase 2BB
CYCLOSPORIN A
Fred Hutchinson Cancer Center
Phase 3BB
CARMUSTINE
Fred Hutchinson Cancer Center
Phase 2BB

View all 28 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →